Compare
Wealthfront Corp vs Core Scientific, Inc./tx vs Resolute Holdings Management, Inc. vs Strategy Inc
| Latest fiscal year | Wealthfront Corp WLTH | Core Scientific, Inc./tx CORZ | Resolute Holdings Management, Inc. RHLD | Strategy Inc MSTR |
|---|---|---|---|---|
| Year ended | 2026-01-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $364.99M | $319.02M | $462.06M | $477.23M |
| Revenue growth (YoY) | +18.2% | -37.5% | +9.9% | +3.0% |
| Gross margin | 89.6% (computed) | 11.9% | 56.3% | 68.7% |
| Operating margin | n/a | -77.0% | 31.0% | n/m |
| Net margin | -11.5% | -90.5% | -1.3% | -806.3% |
| Net income | -$42.07M | -$288.62M | -$5.92M | -$3.85B |
| EPS (Diluted) | -$0.76 | -$0.88 | -$0.69 | -$15.23 |
| Operating cash flow | $152.19M | $278.25M | $196.09M | -$67.24M |
| Free cash flow | n/a | -$450.75M | $189.23M | -$75.45M |
| Cash & equivalents | $440.81M | $311.38M | $161.37M | $2.30B |
| Total assets | $1.42B | $2.35B | $333.42M | $61.64B |
| Total liabilities | $801.04M | $3.31B | $255.65M | $10.60B |
| Shareholders' equity | $614.69M | -$962.74M | $6.52M | $44.12B |
| Return on year-end equity | -6.8% | n/a | -90.8% | -8.7% |
| Shares outstanding | 150.31M | 314.23M | 8.50M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Wealthfront Corp | Core Scientific, Inc./tx | Resolute Holdings Management, Inc. | Strategy Inc |
|---|---|---|---|---|
| Latest | $364.99M Ended 2026-01-31 | $319.02M Ended 2025-12-31 | $462.06M Ended 2025-12-31 | $477.23M Ended 2025-12-31 |
| 1 year earlier | $308.86M Ended 2025-01-31 | $510.67M Ended 2024-12-31 | $420.57M Ended 2024-12-31 | $463.46M Ended 2024-12-31 |
| 2 years earlier | $216.71M Ended 2024-01-31 | $502.40M Ended 2023-12-31 | n/a | $496.26M Ended 2023-12-31 |
| 3 years earlier | n/a | $640.31M Ended 2022-12-31 | n/a | $499.26M Ended 2022-12-31 |
| 4 years earlier | n/a | $544.48M Ended 2021-12-31 | n/a | $510.76M Ended 2021-12-31 |